AI PRODUCTS ❯
TheraPixel
Radvise - Breast cancer

Parent Company:

TheraPixel

Product:

Radvise - Breast cancer

Radvise proposes to radiologists an automated first-reading service with the level of performance of an experienced peer.

Their AI is dedicated to breast cancer screening. That algorithm recently won the 2018 Digital Mammography Challenge by improving by 5% the number of false positives compared to the state of the art.


anatomy
Breast
Subspecialty
Body
Modality
Mammo
Research
Approved
No FDA Pending products from this vendor